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Following exposure to vaccines, antigen-specific
CD8+ T cell responses develop as long-termmemory
pools. Vaccine strategies based on adenoviral vec-
tors, e.g., those developed for HCV, are able to
induce and sustain substantial CD8+ T cell popula-
tions. How such populations evolve following vacci-
nation remains to be defined at a transcriptional
level. We addressed the transcriptional regulation
of divergent CD8+ T cell memory pools induced by
an adenovector encoding a model antigen (beta-
galactosidase). We observe transcriptional profiles
that mimic those following infection with persistent
pathogens, murine and human cytomegalovirus
(CMV). Key transcriptional hallmarks include upregu-
lation of homing receptors and anti-apoptotic path-
ways, driven by conserved networks of transcription
factors, including T-bet. In humans, an adenovirus
vaccine induced similar CMV-like phenotypes and
transcription factor regulation. These data clarify
the core features of CD8+ T cell memory following
vaccination with adenovectors and indicate a con-
served pathway for memory development shared
with persistent herpesviruses.
INTRODUCTION
After viral infection, naive antigen-specific CD8+ T cells clonally
expand and differentiate. Massive proliferation and differentia-
tion to effector T cells is coupled to changes in homing, function,
and gene expression, leading to CD8+ T cell memory. Defining
mechanisms that drive effective CD8+ T cell memory pools is
critical for the design of vaccines.1578 Cell Reports 13, 1578–1588, November 24, 2015 ª2015 The AuBroadly, two subsets of memory CD8+ T cells are described:
central memory CD8+ T cells (TCM) and the effector memory
CD8+ T cells (TEM) (Sallusto et al., 1999). ‘‘Central’’ memory pools
are typically contracted memory populations that express
lymph-node-homing markers (CD62L and CCR7). ‘‘Effector
memory’’ subsets lack these and are found distributed in tissues,
e.g., lung and liver. These pools are linked to infection with
persistent viruses, the best examples being human and murine
cytomegaloviruses (HCMV and MCMV).
A characteristic of the CMV immunobiology is the induction
of an expanded, sustained effector-memory T cell response to
specific epitopes, a phenomenon termed CD8+ T cell ‘‘memory
inflation’’ (Karrer et al., 2003). In parallel, classic ‘‘non-inflating,’’
central memory responses develop against many epitopes.
Molecular profiling of CMV-specific CD8+ T cells in humans re-
vealed that the development of CMV-specific CD8+ T cells is
a dynamic process, with key features of the HCMV-specific
CD8+ T cell phenotype installed early after infection (Hertoghs
et al., 2010).
CD8+ T cell memory induced by vaccines could provide pro-
tection against complex pathogens. Whereas CMV-based vec-
tors show promise in studies of SIV infection (Hansen et al.,
2011), such viruses are complex. One technology that has
shown potency in generation of antiviral T cell pools in clinical
studies is based on replication-deficient adenoviral vectors.
Several trials have indicated such vectors are safe and can
induce substantial immune responses against pathogens such
as HCV (Barnes et al., 2012; Colloca et al., 2012).
Studies of vaccine-induced T cell responses in a murine
model using a recombinant replication-deficient HuAd5 vector
expressing lacZ (Ad-lacZ) (Bolinger et al., 2013) revealed two
distinct pathways for memory—an inflationary response to
one epitope and a typical contracting response to a second
epitope. The sustained response showed phenotypic features
typical of effector memory and was enriched in tissues,
whereas the reverse was true for the contracting response.thors
Figure 1. Frequency, Function, and Gene Expression Signature of MCMV-Specific CD8+ T Cells
C57BL/6 mice were infected intravenously (i.v.) with 1 3 106 pfus MCMV.
(A) Tetramer staining for M38- and M45-specific CD8+ T cells on 7 and 50 days postinfection in spleen. Mean percentages of live tetramer+ CD8+ T cells are
indicated (n = 8; mean ± SEM).
(B) Time course for M38- (red) and M45- (blue) specific CD8+ T cells. Splenocytes from 0, 7, 21, 50, and 100 days postinfection mice were stained with tetramers
and analyzed by flow cytometry. Mean percentages of live tetramer+ CD8+ lymphocytes are indicated (n = 8; mean ± SEM).
(legend continued on next page)
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Because these peptide epitopes are both derived from the
same expressed transgene, this model provides a controlled
system for analysis of two divergent vaccine-induced memory
pools.
Here, we define the transcriptional changes inMCMV infection
and Ad-LacZ vaccination and addressed to what extent parallel
changes can be observed in human memory pools induced by
CMV and adenoviral vectors. Our data clearly show that a subset
of stable memory CD8+ T cell responses, whether induced by
vaccine vectors or natural virus, in mouse and man, display a
common molecular profile divergent from that of acute effector,
central memory, and exhausted CD8+ T cells.
RESULTS
Two Functional and Transcriptionally Distinct Memory
Patterns of MCMV-Specific CD8+ T Cells
To establish a data set for gene expression in CD8+ T cell memory
pools in the setting of a persistent infection, we analyzed thewell-
characterized model of MCMV infection. This has the advantage
of a parallel human data set for comparison (Hertoghs et al.,
2010). Infection of C57BL/6 mice with MCMV resulted in two
distinct CD8+ T cell responses, the conventional (non-inflationary)
and the expanded (inflationary) CD8+ T cell response in blood,
spleen, and organs (liver or lung; Figures 1A, 1B; Figure S1A).
An analogous profile was observed whenM45- andM38-specific
CD8+Tcellswereanalyzed for IFNgandTNFaproduction (Figures
1C and 1D). Furthermore, the expression of chemokines XCL1,
CCL3, CCL4, CCL5, and CCL9 (Figure 1G) and LAMP1 followed
the same pattern. These results confirm previous data that, after
MCMV infection, two distinct types of CD8+ T cell responses are
induced and demonstrate that both types of CD8+ T cells retained
polyfunctionality over time (Munks et al., 2006; Sierro et al., 2005).
To generate gene-expression profiles of MCMV-specific mem-
ory and effector CD8+ T cells, M38- and M45-specific CD8+
T cells from days 7 and 50 postinfection were tetramer sorted.
As naive controls, sorted CD62Lhi CD44lo CD8+ T cells from naive
C57BL/6 mice were used (Figure S1B). We compared gene
expression in M38- and M45-specific CD8+ T cells from day 7
and day 50 to naive CD8+ T cells. Considering genes which
were >2-fold differentially expressed over naive CD8+ T cells
(adjusted p < 0.01) revealed a total of 627 upregulated and 246
downregulated genes for the M45-specific population on day 7
postinfection and 400 up- and 168 downregulated genes on(C) Representative flow cytometry plots of splenocytes producing IFNg or TNFa s
gated on live lymphocytes. Numbers indicate the percentage of IFNg- and TNFa
(D) Time course plotting the percentage of M38- (red) or M45- (blue) specific CD8
the M38 or M45 peptide. Mean percentage of IFNg and TNFa producing cells w
(E) Number of genes upregulated (red) and downregulated (blue) in M38- and M4
T cells. Filter criteria of at least 2-fold change with p% 0.05 compared to naive C
(F) Venn diagram showing the number of differentially expressed genes between
specific CD8+ T cells 7 (orange) and 50 (blue) days postinfection. Filter criteria of a
Upregulated genes are indicated in red and downregulated genes in blue.
(G) Representative flow cytometry plots of splenocytes expressing LAMP1 or pro
days 7 and 50 postinfection, gated on live lymphocytes (n = 8; ±SEM). Longitudin
specific CD8+ T cells from the spleen producing effector molecules after stimulat
CCL3-, CCL4-, CCL5-, and CCL9-positive cells within the CD8+ T cell compartm
See also Figure S1.
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tal of 964geneswere upregulated and 667 genes downregulated,
rising to 1,088 up- and 553 downregulated genes for the late,
inflating M38-specific CD8+ T cells (Figure 1E; GEO: GSE73314).
Comparison showed that the expression profiles of the four
populations differed markedly (Figure 1F). M45-specific CD8+
T cells downregulated a large number of genes from the acute
phase as they entered the central memory phase and most
closely resembled naive CD8+ T cells. In contrast, M38-specific
CD8+ T cells maintained expression of many of their acute phase
genes (1,324 shared genes), also acquiring inflation-specific
genes, totaling overall the highest number of differentially ex-
pressed genes (Figure 1F). These data confirm that MCMV, on
the transcriptional level, clearly induced two distinct CD8+
T cell memory responses maintained in parallel.
Inflationary CD8+ T Cell Memory Induced by a Non-
replicating Adenovirus Vector
We next addressed the qualities of the vaccine-induced re-
sponses following administration of a replication-deficient bgal-
recombinant adenovirus vector (Ad-LacZ) (Bolinger et al., 2013).
Intravenous (i.v.) immunization of C57BL/6 mice with Ad-LacZ
induced two types of CD8+ T cell responses to bgal. bgal96- and
bgal497-specific CD8
+ T cells displayed similar expansion on
day 21 postimmunization, but at day 50, bgal96-specific CD8
+
T cells had further increased to 13%of total CD8+ T cells, whereas
bgal497-specific CD8
+ T cells contracted (Figures 2A and 2B).
Consistent with previous studies (Bolinger et al., 2013), these re-
sponses maintained functionality and were enriched in tissues
such as lung and liver (data not shown).
To examine further the function and stability of vaccine-
induced responses, we used an adoptive transfer approach.
Cells fromCD45.1+mice were transferred at different time points
after vaccination to CD45.2+-vaccinated or naive mice and
tracked using tetramers. The extended CD8+ T cell responses
were sustained over 8 weeks in the recipients, even in the
absence of antigen, maintaining their phenotype (CD44hi,
CD62Llo, CD27lo, and CD127lo) and distributing to tissues such
as liver and lung (data not shown). Overall, these features are
consistent with those of a stable memory T cell pool.
To assess the T cell transcriptome of bgal-specific CD8+ T cells
after Ad-LacZ immunization, a gene expression array analysis
of tetramer-sorted bgal-specific CD8+ T cells from day 21 and
day 100 and of naive CD8+ T cells (CD62Lhi and CD44lo) wastimulated with either M38 or M45 peptide in mice 7 and 50 days postinfection,
-positive CD8+ T cells (n = 8; mean ± SEM).
+ T cells from the spleen producing IFNg and TNFa after stimulation with either
ithin the CD8+ T cell compartment is indicated (n = 8; mean ± SEM).
5-specific CD8+ T cells 7 and 50 days postinfection, compared to naive CD8+
D8+ T cells are shown.
M38-specific CD8+ T cells 7 (yellow) and 50 (red) days postinfection and M45-
t least 2-fold change with p% 0.05 compared to naive CD8+ T cells are shown.
ducing effector molecules stimulated with either M38 or M45 peptide in mice
al flow cytometry analysis shows the percentage of M38- (red) or M45- (blue)
ion with either the M38 or M45 peptide. Mean percentages of LAMP1-, XCL1-,
ent are indicated (n = 8; ±SEM).
thors
Figure 2. Frequency and Gene Expression Signature of Vaccine-Induced bgal-Specific CD8+ T Cells
C57BL/6 mice were immunized i.v. with 1 3 109 pfus Ad-LacZ.
(A) Representative flow cytometry plots of tetramer staining for bgal96- and bgal497-specific CD8
+ T cells on 21 and 100 days postimmunization in the spleen.
Mean percentage of live tetramer-positive CD8+ T cells is indicated (n = 10; mean ± SEM).
(B) Time course for bgal96- (red) and bgal497- (blue) specific CD8
+ T cells. Splenocytes from 0, 21, 50, and 100 days postimmunization were stained with tetramers
and analyzed by flow cytometry. Mean percentages of live tetramer-positive CD8+ T cells are indicated (n = 5; mean ± SEM).
(C) Venn diagram showing the number of differentially expressed genes between bgal96-specific CD8
+ T cells 21 (yellow) and 100 (red) days postimmunization
and bgal497-specific CD8
+ T cells 21 (orange) and 100 (blue) days postimmunization. Filter criteria of at least 2-fold change with p% 0.05 compared to naive CD8+
T cells are shown. Upregulated genes are indicated in red and downregulated genes in blue.
See also Figure S2.performed. By only considering genes that were at least 2-fold
differentially expressed (adjusted p < 0.01) compared to naive
CD8+ T cells, we found a total of 937 up- and 403 downregulated
genes for bgal96-specific (expanded) CD8
+ T cells (Figure 2C). By
directly comparing the bgal96-specific CD8
+ T cell populationwith
the bgal497-specific memory population, it is evident that memory
bgal96-specific CD8
+ T cells showed a distinct expression pro-
file—neither identical to effector CD8+ T cells nor memory
bgal497-specific CD8
+ T cells (Figure 2C). These data confirm pre-
vious analyses indicating that two distinct memory pools are
induced in parallel following Ad-lacZ immunization (Bolinger
et al., 2013; GEO: GSE73314).
Combined Analysis Reveals a Conserved Expression
Profile and Phenotype
Genesetenrichmentanalysis (GSEA)confirmedenrichmentof the
significantly up- and downregulated genes of the inflating bgal96-
and M38-specific CD8+ T cells (Figure S2A). Overall, these com-
parisons revealed that M38- and bgal96-specific inflating CD8
+
T cells shared 663 upregulated and 290 downregulated genes
(compared to naive CD8+ T cells; Figure S2B). We analyzed the
transcriptional changes in the MCMV-induced and vaccine-
induced memory pools, focusing on the cell cycle, apoptosis,
TFs, and receptors for cytokines and chemokines, similar to an
analysis of human CMV infection (Hertoghs et al., 2010).
For cell-cycle-related genes, the highly upregulated genes in
the expanded populations in both models included MKI67 (Ki-
67), a marker of proliferation. Its expression was confirmed by
FACS, and both models showed a similar profile. By day 100,
the levels of proliferation in the expanded population had drop-
ped to a similar level to those in the contracted memory (Figures
3A and 3B).
For cell survival, whereas expanded T cells maintained ex-
pression of genes seen in acute infection, contracted memoryCell Repexhibited a similar expression profile to that of naive CD8+
T cells (Figure 3C). For example, FACS analysis of the anti-
apoptotic protein Bcl-2 demonstrated downregulation in the
acute phase in all responses but recovered at later time points
only in the classical memory pools (Figure 3D).
‘‘Tuning’’ of function through inhibitory and activation recep-
tors occurs on T cells. We analyzed CD27 and CD357 (Watts,
2005) and confirmed reduced expression of these stimulatory
receptors on expanded CD8+ T cells (data not shown). Simi-
larly, for both models, we extended previous data (Bolinger
et al., 2013; Snyder et al., 2008) and showed overexpression
of Klrc1 (NKG2A), Klrg1 (KLRG1), Klre1, Klra1 (Ly-49c), and
Klrk1 (Nkg2d) in the expanded responses and unique expres-
sion of Ly49C mRNA, confirmed by flow cytometry analysis or
qPCR (data not shown). Further analysis of inhibitory mole-
cules associated with exhaustion (Blackburn et al., 2009;
Wherry et al., 2007) revealed that the genes for PD-1, TIM3,
CD160, LAG3, and BTLA were expressed after infection and
immunization (data not shown). However, FACS analysis of
PD1, TIM3, and BTLA showed high expression of these
markers on days 7/21 followed by a gradual decrease in the
memory phase to levels similar to naive CD8+ T cells (Fig-
ure 3E). Consistent with retained functionality, the expression
of granzymes, such as Gzma, Gzmb, Gzmm, and Gzmk were
upregulated in both models, compared to naive CD8+ T cells
(data not shown).
Long-term maintenance of cell function is linked to cytokine
signaling (‘‘signal 3’’). IL-7Ra (CD127) and IL-15Rb (CD122)
have been shown to be downregulated on inflationary CD8+
T cells (Bolinger et al., 2013; Snyder et al., 2008). We confirmed
downregulation of IL-7Ra as well as downregulation of IL-6Ra
(Figure 4A). These data were confirmed by FACS (Figure 4B).
Inflationary CD8+ T cells also showed marked alterations in
chemokine receptors (Figure 4A). We confirmed upregulationorts 13, 1578–1588, November 24, 2015 ª2015 The Authors 1581
of CX3CR1 and relative downregulation of CXCR3 on tetramer+
CD8+ T cells by FACS (Figure 4B).
Next, we further focused on the differential expression of
mRNAs of TFs (Figure 4C). T-bet and Eomes, critical for T cell
memory formation, were upregulated on both specificities of
CD8+ T cells in the acute phase: on M38- and bgal96-specific
CD8+ T cells, Eomes then decreased to levels similar to that of
naive CD8+ T cells (Figure 4D). T-bet expression, however,
showed divergence in thememory phase, being low on contract-
ing CD8+ T cells and remaining high on expanded CD8+ T cells;
after adenovector vaccination, Tbet remained high on 60%of the
expanded cell population at day 200 versus <10%on contracted
memory at that time point (Figure S3A). Relative expression of
other TFs such as Rog (repressor of GATA), Blimp-1 (Prdm1),
Bcl-6, Id2, and Id3 were also consistent with this (Figure S3B;
data not shown).
To define distinctions between memory populations further—
and the role of TFs in driving these—we used principal-compo-
nent analysis (PCA) (Figure S4). These data demonstrated that
all antigen-experienced cell types cluster separately from naive
cells and, compared to the ‘‘acute’’ sample, the classic memory
pools (M45/bgal497) regress toward the naive cell position
whereas the expanded (M38/bgal96) populations further extended
the distance. The PCA analysis was confirmed when only using
significantly modulated TFs (post-ANOVA test; Figure S4), indi-
cating that the principal components separating these memory
populations derived from changes in a limited number of TFs.
Finally, many of these features of MCMV-induced and adeno-
vector-inducedmemorycells closely resembleddata fromastudy
of HCMV infection (Hertoghs et al., 2010). Similar GSEA profiles
were seen using expression sets based onMCMV infection (con-
firminga recent analysis;Quinnet al., 2015) and, strikingly, adeno-
virus vaccination (FigureS4). Additionally, fromGSEAanalyseson
the TF subset, we confirmed that TFs upregulated in HCMV (Her-
toghs et al., 2010) are enriched in upregulated TFs post-MCMVor
-adenovector, notably Tbet (ranked 1; Figure S4).
Preserved Phenotype, Function, and TF Expression in
Human-Adenoviral-Vaccine-Induced Responses
To assess in depth whether such changes in T cell phenotype and
in TF expression could be observed in human-adenovector-vac-
cine-induced responses, we analyzed further CD8+ T cells primed
using a chimpanzee adenovirus strategy (ChAd3), specific for
dominant HCV epitopes from NS3 (NS395, HLA-A2 restricted
and NS3103 HLA-A1 restricted). We compared them to CMV-spe-
cific responses from the same individuals. We addressed (1)
whether a CMV-like effector memory phenotype could be
observed and (2) whether this was associated with a Tbet-high
sustained memory subset.
First, using a CYToF data set (Swadling et al., 2014), we
analyzed the distribution of effector-memory-associated pheno-
typic markers on CMV- and HCV-specific (i.e. vaccine-induced)
cells in parallel. This demonstrated a shared phenotype and one
distinct from T cell responses to the non-persistent pathogen
influenza (Figure 5A), most clearly seen in analysis of CD57.
Overlapping populations of CD57+ CD127low CD8+ T cell pools
can be seen in both CMV-specific and adenovirus-induced re-
sponses. PCA revealed overlapping distribution of CMV-specific1582 Cell Reports 13, 1578–1588, November 24, 2015 ª2015 The Auand vaccine-induced CD8+ T cell responses and distinct from
those induced by influenza infection (Figure 5B).
Next, we analyzed the expression of two TFs—Tbet and
Eomes. In bulk CD8+ T cell populations, these showed associa-
tions with distinct memory pools, with highest Tbet levels in
Tem and Temra pools (Figure 5C). In antigen-specific cells,
we identified similar patterns of Tbet and Eomes regulation in
CMV- and vaccine-induced cells, with enrichment for Tbet+
Eomes cells in the HCV-specific vaccine populations (Fig-
ure 5D). This distribution wasmaintained when the virus-specific
cells were analyzed following subdivision using CCR7/CD45RA
expression (Figure S5A) or within a single individual (Figure S5B)
or comparing populations that had received only adenoviral
vaccination and those where there had been boosting using an
MVA construct (Figure S5C).
The data confirmed that the adenovirus-vaccine-induced re-
sponses in humans are dominated by effector memory popula-
tions. These are high in Tbet and relatively low in Eomes, similar
to CMV-specific responses from the same individuals.
DISCUSSION
Memory T cells are considered long-lived cells that require little if
any antigen re-encounter for survival. However, continued low-
level stimulation through persistence of antigen is common
in vivo. We hypothesized the latter could underlie the ability of
adenoviral vectors to promote T cell responses in humans.
Here, by profiling CMV-specific and adenovirus-vaccine-spe-
cific memory CD8+ T cells, we identified patterns of CD8+
T cell evolution that are (1) conserved between infection and
vaccination and (2) consistent between mouse and man.
Memory inflation has been shown to be independent of initial
immunodominance in MCMV (Karrer et al., 2004), and inflation-
ary epitopes are immunoproteasome independent—suggesting
they are not presented on DCs (Hutchinson et al., 2011). The cur-
rent model is that repetitive antigen presentation occurs on a
non-classical antigen-presenting cell (APC), potentially in the
vascular endothelium or a non-hematopoietic (nh) lymph node
cell (Smith et al., 2014; Torti et al., 2011). A separate study with
a recombinant adenovirus vector concluded that nhAPC might
play a role in memory (Bassett et al., 2011).
The expanded CD8+ T cell pools downregulated the anti-
apoptotic marker Bcl-2 compared to conventional memory
CD8+ T cells. However, the anti-apoptotic Bcl-XL was uniquely
upregulated. Bag3, another anti-apoptotic molecule, was highly
expressed, andBim, a pro-apoptoticmarker, wasdownregulated
(Figure 3C). Bcl-XL expression can be induced by CX3CR1
(Boehme et al., 2000), which was highly upregulated in inflation
(Figure 4B). Co-stimulation via 4-1BB has been shown to be crit-
ical formemory inflation (Humphreys et al., 2010); because 4-1BB
also inducesBcl-XL (Sta¨rck et al., 2005), we hypothesize that both
CX3CR1 and 4-1BB contribute to survival of CD8+ T cells.
CD8+ effector memory pools express high levels of T-bet
and to a lower extent Eomes. T-bet expression is induced by
TCR signaling and amplified by IL-12- and mTOR-mediated
signals (Intlekofer et al., 2008). This program seems to be pre-
sent in HCV-specific CD8+ T cells induced using ChAd3 in volun-
teers. Such pools show sustained effector-memory phenotype,thors
(legend on next page)
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analogous to hCMV-specific responses, and a T-bethi/Eomeslo
status, consistent with the mouse data. This is particularly reso-
nant for HCV-specific responses, because this is the transcrip-
tional pattern linked with clearance of virus (Paley et al., 2012).
The frequencies of responses induced by vaccination in humans
do not reach those seen in ‘‘inflationary’’ models; however, they
do reflect frequencies seen with intramuscular as opposed to
(optimized) i.v. inoculation, with the same phenotypic/transcrip-
tional changes noted (Bolinger et al., 2013).
Overall, we have identified gene sets modulated in CD8+
T cells post-adenoviral vaccine compared to acute effector
CD8+ T cells and to conventional memory CD8+ T cells. By
comparing these to the ‘‘inflating’’ CD8+ T cells from MCMV-in-
fected animals, we show the CD8+ T cell gene profile is distinct
from that seen in exhaustion and conventional memory and sus-
tains amemory development program likely linked with low-level
antigen persistence. Such CD8+ T cells possess a conserved
phenotypic and functional pattern, underpinned by a core set
of TFs. We show that this program of memory induction is repro-
duced in chimpanzee-adenovirus clinical vaccine trials, with im-
plications for immunity induced by such regimens in humans.
EXPERIMENTAL PROCEDURES
Ethics Statement
Mouse experiments were performed according to UK HomeOffice regulations
(project license number PPL 30/2235 and 30/2744) and after review and
approval by the local ethical review board at the University of Oxford.
Viruses
MCMV strain (Strain Smith; ATCC: VR194) was used and kindly provided by
Professor U.H. Koszinoswki, Department of Virology, Max von Pettenkofer
Institute. MCMV was propagated and titrated on NIH 3T3 cells (ECACC),
stored at 80C, and injected i.v. at a dose of 2 3 106 pfus.
Adenoviral Vector
Recombinant adenovirus expressed the bgal protein under the control of the
human CMV promoter (Ad-LacZ; Krebs et al., 2005). Ad-LacZ was propagated
on HER-911 cells and purifiedwith the Vivapure AdenoPack 20 (Sartorius; Ste-
dim Biotech). Virus titer was determined in a cytopathic effect assay (Krebs
et al., 2005). Ad-LacZ was stored at 80C in PBS and injected i.v. at a
dose of 2 3 109 pfus.
Mice
C57BL/6 mice were obtained from Harlan, kept under conventional conditions
in individually ventilated cages, and fed with normal chow diet.Figure 3. Turnover, Survival, and Expression of Inhibitory Receptors o
C57BL/6 mice were infected i.v. with 1 3 106 pfus MCMV or immunized i.v. with
(A) Longitudinal analysis of the percentage of cells expressing Ki67 onMCMV-spe
0, 7, 21, 50, and 100 postinfection or postvaccination, measured by flow cytome
(B) Representative flow cytometry plots show the expression of Ki67 in the spleen
M38- or M45-specific (left panel) and bgal96- or bgal497-specific (right panel) CD
(C) Heatmap showing mRNA expression levels of proteins involved in apoptosis m
days 7 and 50 postinfection (left panel) and naive CD8+ T cells, bgal96-, and bgal497
red indicate upregulated genes, and shades of blue indicate downregulated genes
T cells, are shown.
(D) Longitudinal analysis of the percentage of cells expressing Bcl2 onMCMV-spe
0, 7, 21, 50, and 100 postinfection or postvaccination, measured by flow cytome
(E) Flow cytometry analysis showing the percentage or the MFI of cells expressing
CD8+ T cells (blue; n = 6–8; ±SEM) and on bgal96- (red) and bgal497-specific (blue
PD-1, TIM-3, and BTLA and are gated on live naive (green) M38/bgal96-specific
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Peptides were MCMV, M38316–323 (SSPPMFRV; Munks et al., 2006), and
M45985–993 (HGIRNASFI; Gold et al., 2002; Proimmune) and bgal96–103 (DA-
PIYTNV; Overwijk et al., 1997) and bgal497–504 (ICPMYARV; Oukka et al.,
1996; Mimotopes).
Antibodies
Antibodies were obtained from eBioscience, BD Bioscience, BioLegend, Ab-
cam, R&D Systems, and Jackson ImmunoResearch Laboratories.
Flow Cytometry
Single-cell suspensions were generated from the indicated organs, and 1 3
106 cells were incubated with the indicated mAb at 4C for 20 min. For PBL
samples, erythrocytes were lysed with FACS Lysing Solution (BD PharMin-
gen). Cells were analyzed by flow cytometry using a BD LSR II flow cytometer
and FlowJo (Treestar), gated on viable leukocytes using the live/dead fixable
near-IR dead cell stain kit from Invitrogen.
Intracellular Staining and Peptide Stimulation
Following surface staining, cells were fixed and permeabilized using the
FOXP3 Fixation/Permeabilisation Kit from eBioscience. Cells were resus-
pended in permeabilization buffer containing the appropriate amount of
antibody and incubated for 30 min at 4C. For peptide stimulation, see
Supplemental Experimental Procedures.
Construction of Tetrameric MHC Class I Peptide Complexes
MHC class I monomers complexed with M38 (H-2Kb), M45 (H-2Db), and bgal
(H-2Kb) were produced as previously (Altman et al., 1996) and tetramerized by
addition of streptavidin-PE (BD Bioscience) or streptavidin-APC (Invitrogen).
Aliquots of 1 3 106 cells or 100 ml of whole blood were stained using 50 ml of
a solution containing tetrameric class I peptide complexes at 37C for
20 min followed by staining with mAbs.
Sorting Cells by MACS
CD8+ T cells were isolated from spleens and single-cell suspensions prepared,
resuspended in MACS buffer at a concentration of 107 cells/90 ml, and purified
by negative selection using the CD8+ T cell selection kit/AutoMACS (Miltenyi
Biotec).
Cell Sorting by MoFLO
For cell sorting, at least four spleens were pooled per sort using MoFlo
(Beckman Coulter Genomics). Splenocyte samples depleted of erythro-
cytes and enriched for CD8+ T cells using MACS beads were stained
with saturating concentrations of antibody and tetramer, incubated for
1 hr on a rolling platform at 4C, washed, filtered, and resuspended.
Sorted cells were pelleted at 9,000 rpm for 10 min and snap frozen using
methanol and dry ice. Reanalysis of sorted cells indicated a purity of over
95%.n Sustained Memory CD8+ T Cell Pools
1 3 109 pfus Ad-LacZ.
cific (left panel) and bgal-specific CD8+ T cells (right panel) in the spleen on days
try (n = 6–8; ±SEM).
on days 7 and 50 postinfection or d21 and d100 postvaccination gated on live
8 T cells.
easured by microarray analysis of naive, M38-, and M45-specific CD8+ T cells
-specific CD8+ T cells days 21 and 100 postvaccination (right panel). Shades of
. Filter criteria of at least 2-fold changeswith p% 0.05, compared to naive CD8+
cific (left panel) and bgal-specific CD8+ T cells (right panel) in the spleen on days
try (n = 6–8; ±SEM).
the inhibitory receptors PD1, TIM3, and BTLA on M38- (red) and M45-specific
) CD8+ T cells in the spleen (n = 6–8; ±SEM). Histograms show expression of
(red) and M45/bgal497-specific CD8
+ T cells (blue).
thors
Figure 4. Distinct Cytokine and Chemokine
Receptor Expression and Individual Tran-
scription Regulator Profile on Expanded
CD8+ T Cells Compared to Conventional
Memory CD8+ T Cells
(A) Heatmap showing mRNA expression levels of
cytokine and chemokine receptors measured by
microarray analysis of naive, M38-, and M45-spe-
cific CD8+ T cells days 7 and 50 postinfection (left
panel) and naive, bgal96-, and bgal497-specific
CD8+T cells days 21 and100postvaccination (right
panel). Shades of red indicate upregulated genes,
and shades of blue indicate downregulated genes.
Filter criteria of at least 2-fold changes with p %
0.05, compared to naive CD8+ T cells, are shown.
(B) Longitudinal flow cytometry analysis showing
the percentage of IL-6Ra (CD126), CX3CR1, and
CXCR3 expression on M38/bgal96- (red) and M45/
bgal497-specific CD8
+ T cells (blue) in the spleen at
days 0, 7, 21, 50, and 100 postinfection/immuni-
zation (n = 6–8; ±SEM). Histograms show expres-
sion of indicated markers, gated on live naive
(green) M38/bgal96- (red) andM45/bgal497-specific
CD8+ T cells (blue).
(C) Heatmap showing mRNA expression levels of
transcriptional regulators measured by microarray
analysis of naive, M38-, and M45-specific CD8+
T cells days 7 and 50 postinfection (left panel) and
naive CD8+ T cells and bgal96- and bgal497-specific
CD8+ T cells days 21 and 100 postvaccination (right
panel). Shades of red indicate upregulated genes,
and shades of blue indicate downregulated genes.
Filter criteria of at least 2-fold changes with p %
0.05, compared to naive CD8+ T cells, are shown.
(D) Flow cytometry analysis showing the MFI of
cells expressing the TFs EOMES and Tbet onM38-
(red) and M45-specific CD8+ T cells (blue; n = 6–8;
±SEM) and on bgal96- (red) and bgal497-specific
(blue) CD8+ T cells in the spleen (n = 5–9; ±SEM).
Histograms show expression of EOMES and Tbet
and are gated on live naive (green), M38/bgal96-
specific CD8+ T cells (red), and M45/bgal497-spe-
cific CD8+ T cells (blue).
See also Figures S3 and S4.RNA Extraction and Microarray Analyses
Total RNA was isolated from sorted cells using the mirVana Kit (Ambion).
RNA integrity was checked using Agilent 2100 Bioanalyzer, and samples
with a RIN value of 8 or more were used for amplification. cDNA was synthe-
sized and cRNA made using Illumina Total Prep RNA amplification
Kit (Ambion). Samples were hybridized to Illumina MouseWG-6 v2.0.Cell Reports 13, 1578–1588, NoFor microarray data analysis, see the Supple-
mental Experimental Procedures.
Statistical Analysis of Real-Time and Flow
Cytometry Data
Unpaired two-tailedStudent’s testwas used. Statis-
tical data analysis was performed using Graph-Pad
Prism version 5.0a for MACs (GraphPad Software).
Human Vaccination Protocols
The Ad6, ChAd3, and MVA vectors encoding the
NS3-5B region of genotype 1B (Ad6-NSmut,
based on sequence accession number M58335)
and vaccination schedules have been describedpreviously (Barnes et al., 2012; Swadling et al., 2014; ClinicalTrial.gov data-
base ID: NCT01070407 and NCT01296451).
Human Pentamer Staining and Flow Cytometry
Pentamer staining was as previously (Swadling et al., 2014). For staining de-
tails, see the Supplemental Experimental Procedures.vember 24, 2015 ª2015 The Authors 1585
(legend on next page)
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Mass Cytometry Using CyTOF
Detailed methodology and validation of the mass cytometry used here are
described elsewhere (Newell et al., 2012). T cell phenotype and function
were determined by mass cytometry analysis on frozen PBMCs from two vol-
unteers receiving ChAd3-NSmut and MVA-NSmut. Samples were taken
14 weeks after MVA-NSmut boost vaccination. Two healthy controls each
for CMV and FLU, previously shown to have a detectable T cell response by
pentamer FACS staining, were also included. For PCA details, see Supple-
mental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.10.034.
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